ORCID2025
Lisa R. Goldberg, Britahny M. Baskin, Jacob A. Beierle, Yahia Adla, Julia C. Kelliher, Emily J. Yao, Stacey L. Kirkpatrick, Eric R. Reed, David Jenkins, Jiayi Cox, et al. 2025. “Atp1a2 and Kcnj9 Are Candidate Genes Underlying Sensitivity to Oxycodone-Induced Locomotor Activation and Withdrawal-Induced Anxiety-Like Behaviors in C57BL/6 Substrains.” Genes, Brain, and Behavior 24:e70009. 10.1111/gbb.70009
2024
Azadeh C. Bashi, Elizabeth A. Coker, Krishna C. Bulusu, Patricia Jaaks, Claire Crafter, Howard Lightfoot, Marta Milo, Katrina McCarten, David F. Jenkins, Dieudonne van der Meer, et al. 2024. “Large-scale Pan-cancer Cell Line Screening Identifies Actionable and Effective Drug Combinations.” Cancer Discovery 14 (5): 846–865. 10.1158/2159-8290.CD-23-0388
2023
Mark Roschewski, Manish R. Patel, Patrick M. Reagan, Nakhle S. Saba, Graham P. Collins, Hendrik-Tobias Arkenau, Sven de Vos, Barret Nuttall, Melih Acar, Kathleen Burke, Rafael D. White, Maria Udriste, Shringi Sharma, Brian Dougherty, Daniel Stetson, David Jenkins, Andrew Mortlock, Alessandra Forcina, Veerendra Munugalavadla, & Ian Flinn. 2023. “Phase 1 Study of Acalabrutinib Plus Danvatirsen (AZD9150) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma Including Circulating Tumor DNA Biomarker Assessment.” Clinical Cancer Research 10.1158/1078-0432.CCR-22-2483
2021
Xiaomeng Huang, Yi Qiao, Samuel W. Brady, Rachel E. Factor, Erinn Downs-Kelly, Andrew Farrell, Jasmine A. McQuerry, Gajendra Shrestha, David Jenkins, W. Evan Johnson, Adam L. Cohen, Andrea H. Bild & Gabor T. Marth. 2021. “Novel temporal and spatial patterns of metastatic colonization from breast cancer rapid-autopsy tumor biopsies.” Genome Medicine 13:170. 10.1186/s13073-021-00989-6
W. Evan Johnson, Aubrey Odom, Chelsie Cintron, Mutharaj Muthaiah, Selby Knudsen, Noyal Joseph, Senbagavalli Babu, Subitha Lakshminarayanan, David F. Jenkins, Yue Zhao, Ethel Nankya, C. Robert Horsburgh, Gautam Roy, Jerrold Ellner, Sonali Sarkar, Padmini Salgame and Natasha S. Hochberg. 2021. “Comparing tuberculosis gene signatures in malnourished individuals using the TBSignatureProfiler.” BMC Infectious Diseases 22;21(1):106. 10.1186/s12879-020-05598-z
2019
Gerald J. Sun, David F. Jenkins, Pablo E. Cingolani, Jonathan R. Dry, Zhongwu Lai. 2019. “Optimized data representation and convolutional neural network model for predicting tumor purity.” bioRxiv Preprint. 10.1101/805135
Jasmine A. McQuerry†, David F. Jenkins†, Susan E. Yost, Yuqing Zhang, Daniel Schmolze, W. Evan Johnson, Yuan Yuan, and Andrea H. Bild. 2019. “Pathway activity profiling of growth factor receptor network and stemness pathways differentiates metaplastic breast cancer histological subtypes.” BMC Cancer 19:881. 10.1186/s12885-019-6052-z
† Contributed equally
2018
Zhang, Yuqing, David F. Jenkins, Solaiappan Manimaran and W. Evan Johnson. 2018. “Alternative empirical Bayes models for adjusting for batch effects in genomic studies.” BMC Bioinformatics 19:262. 10.1186/s12859-018-2263-6
David F. Jenkins, Tyler Faits, Emma Briars, Sebastian Carrasco Pro, Steve Cunningham, Joshua D. Campbell, Masanao Yajima, & W. Evan Johnson. 2018. “Interactive single cell RNA-Seq analysis with the Single Cell Toolkit (SCTK).” bioRxiv Preprint. 10.1101/329755
2017
Brady, Samuel W., Jasmine A. McQuerry, Yi Qiao, Stephen R. Piccolo, Gajendra Shrestha, David F. Jenkins, Ryan M. Layer, et al. 2017. “Combating Subclonal Evolution of Resistant Cancer Phenotypes.” Nature Communications 8 (1): 883. 10.1038/s41467-017-01174-3
Goldberg, Lisa R., Stacey L. Kirkpatrick, Neema Yazdani, Kimberly P. Luttik, Olga A. Lacki, R. Keith Babbs, David F. Jenkins, W. Evan Johnson, and Camron D. Bryant. 2017. “Casein Kinase 1-Epsilon Deletion Increases Mu Opioid Receptor-Dependent Behaviors and Binge Eating.” Genes, Brain, and Behavior, June. 10.1111/gbb.12397
Rahman, Mumtahena†, Shelley M. MacNeil†, David F. Jenkins†, Gajendra Shrestha, Sydney R. Wyatt, Jasmine A. McQuerry, Stephen R. Piccolo, Laura M. Heiser, Joe W. Gray, W. Evan Johnson and Andrea H. Bild. 2017. “Activity of Distinct Growth Factor Receptor Network Components in Breast Tumors Uncovers Two Biologically Relevant Subtypes.” Genome Medicine 9 (1): 40. 10.1186/s13073-017-0429-x
† Contributed equally
Ahdesmäki, Miika J., Brad A. Chapman, Pablo Cingolani, Oliver Hofmann, Aleksandr Sidoruk, Zhongwu Lai, Gennadii Zakharov, Mikhail Rodichenko, Mikhail Alperovich, David Jenkins, T. Hedley Carr, Daniel Stetson, Brian Dougherty, J. Carl Barrett, and Justin H. Johnson. 2017. “Prioritisation of Structural Variant Calls in Cancer Genomes.” PeerJ 5 (April): e3166. 10.7717/peerj.3166
2016
Kirkpatrick, Stacey L., Lisa R. Goldberg, Neema Yazdani, R. Keith Babbs, Jiayi Wu, Eric R. Reed, David F. Jenkins, Amanda F. Bolgioni, Kelsey I. Landaverde, Kimberly P. Luttik, Karen S. Mitchell, Vivek Kumar, W. Evan Johnson, Megan K. Mulligan, Pietro Cottone, and Camron D. Bryant. 2017. “Cytoplasmic FMR1-Interacting Protein 2 Is a Major Genetic Factor Underlying Binge Eating.” Biological Psychiatry 81 (9): 757–69. 10.1016/j.biopsych.2016.10.021
Shrestha, Gajendra, Shelley M. MacNeil, Jasmine A. McQuerry, David F. Jenkins, Sunil Sharma, and Andrea H. Bild. 2016. “The Value of Genomics in Dissecting the RAS-Network and in Guiding Therapeutics for RAS-Driven Cancers.” Seminars in Cell & Developmental Biology 58 (October): 108–17. 10.1016/j.semcdb.2016.06.012